IVF - NAYA Biosciences, Inc.
0.868
-0.019 -2.143%
Share volume: 121,585
Last Updated: 03-05-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.89
-0.02
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 11-19-2024 | 11-19-2024 | 05-20-2025 | 08-14-2025 | 11-17-2025 | |
| Assets | |||||||
| Total Assets | 18.318 M | 17.755 M | 17.019 M | 31.744 M | 19.319 M | 18.832 M | |
| Current Assets | 1.725 M | 2.396 M | 1.957 M | 1.569 M | 1.399 M | 1.137 M | |
| Inventories | 266.454 K | 250.066 K | 241.539 K | 216.458 K | 212.611 K | 191.762 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 475.125 K | 942.934 K | 471.591 K | 840.407 K | 549.181 K | 355.891 K | |
| Total Non-current Assets | 3.043 M | 844.198 K | 2.944 M | 710.855 K | 3.113 M | 3.081 M | |
| Property Plant Equipment | 412.196 K | 441.365 K | 415.245 K | 451.247 K | 428.746 K | 405.417 K | |
| Other Assets | 16.181 M | 14.917 M | 14.647 M | 29.724 M | 17.491 M | 17.290 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 18.318 M | 17.755 M | 17.019 M | 31.744 M | 19.319 M | 18.832 M | |
| Total liabilities | 18.308 M | 16.391 M | 17.043 M | 24.430 M | 16.688 M | 12.983 M | |
| Total current liabilities | 8.956 M | 7.952 M | 8.655 M | 18.719 M | 12.463 M | 9.245 M | |
| Accounts Payable | 2.798 M | 2.378 M | 2.655 M | 4.785 M | 2.227 M | 2.391 M | |
| Other liabilities | 8.138 M | 7.266 M | 7.253 M | 4.625 M | 3.183 M | 2.787 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 1.214 M | 1.173 M | 1.134 M | 1.086 M | 1.041 M | 951.668 K | |
| Other liabilities | 8.138 M | 7.266 M | 7.253 M | 4.625 M | 3.183 M | 2.787 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -6.490 M | -6.143 M | -7.667 M | -27.040 M | -7.490 M | -3.029 M | |
| Common stock | 52.925 M | 55.768 M | 55.874 M | 57.834 M | 82.713 M | 90.064 M | |
| Retained earnings | -59.415 M | -61.910 M | -63.541 M | -84.873 M | -90.203 M | -93.092 M |